Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Issued Notice of Allowance on miRNA Used in Cancer Diagnostic

Premium

Rosetta Genomics said this week that it has received a notice of allowance for a US patent application related to a microRNA used in its cancer of unknown primary origin diagnostic.

The application, No. 20080182237, is entitled "Lung Cancer-Related Nucleic Acids," and claims miRNAs, miRNA precursors, and associated nucleic acids associated with lung cancer for the prognosis, diagnosis, and treatment of the disease.

According to Rosetta, it covers miR-451, which is used in its miRview Mets test that is designed to determine the source of cancers of unknown primary origin.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.